Premium
Receptor association and tyrosine phosphorylation of S6 kinases
Author(s) -
Rebholz Heike,
Panasyuk Ganna,
Fenton Timothy,
Nemazanyy Ivan,
Valovka Taras,
Flajolet Marc,
Ronnstrand Lars,
Stephens Len,
West Andrew,
Gout Ivan T
Publication year - 2006
Publication title -
the febs journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 204
eISSN - 1742-4658
pISSN - 1742-464X
DOI - 10.1111/j.1742-4658.2006.05219.x
Subject(s) - p70 s6 kinase 1 , receptor tyrosine kinase , proto oncogene tyrosine protein kinase src , platelet derived growth factor receptor , microbiology and biotechnology , protein kinase b , tyrosine phosphorylation , biology , sh2 domain , map kinase kinase kinase , phosphorylation , chemistry , biochemistry , receptor , growth factor
Ribosomal protein S6 kinase (S6K) is activated by an array of mitogenic stimuli and is a key player in the regulation of cell growth. The activation process of S6 kinase involves a complex and sequential series of multiple Ser/Thr phosphorylations and is mainly mediated via phosphatidylinositol 3‐kinase (PI3K)‐3‐phosphoinositide‐dependent protein kinase‐1 (PDK1) and mTor‐dependent pathways. Upstream regulators of S6K, such as PDK1 and protein kinase B (PKB/Akt), are recruited to the membrane via their pleckstrin homology (PH) or protein–protein interaction domains. However, the mechanism of integration of S6K into a multi‐enzyme complex around activated receptor tyrosine kinases is not clear. In the present study, we describe a specific interaction between S6K with receptor tyrosine kinases, such as platelet‐derived growth factor receptor (PDGFR). The interaction with PDGFR is mediated via the kinase or the kinase extension domain of S6K. Complex formation is inducible by growth factors and leads to S6K tyrosine phosphorylation. Using PDGFR mutants, we have shown that the phosphorylation is exerted via a PDGFR‐src pathway. Furthermore, src kinase phosphorylates and coimmunoprecipitates with S6K in vivo. Inhibitors towards tyrosine kinases, such as genistein and PP1, or src‐specific SU6656, but not PI3K and mTor inhibitors, lead to a reduction in tyrosine phosphorylation of S6K. In addition, we mapped the sites of tyrosine phosphorylation in S6K1 and S6K2 to Y39 and Y45, respectively. Mutational and immunofluorescent analysis indicated that phosphorylation of S6Ks at these sites does not affect their activity or subcellular localization. Our data indicate that S6 kinase is recruited into a complex with RTKs and src and becomes phosphorylated on tyrosine/s in response to PDGF or serum.